PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.51%
Positive revenue growth while ACB.TO is negative. John Neff might see a notable competitive edge here.
7.27%
Gross profit growth under 50% of ACB.TO's 32.21%. Michael Burry would be concerned about a severe competitive disadvantage.
-21.53%
Negative EBIT growth while ACB.TO is at 131.33%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-21.53%
Negative operating income growth while ACB.TO is at 24.94%. Joel Greenblatt would press for urgent turnaround measures.
12.27%
Net income growth under 50% of ACB.TO's 98.06%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.96%
EPS growth under 50% of ACB.TO's 98.36%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
16.96%
Diluted EPS growth under 50% of ACB.TO's 98.36%. Michael Burry would worry about an eroding competitive position or excessive dilution.
5.73%
Share count expansion well above ACB.TO's 8.60%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.73%
Diluted share count expanding well above ACB.TO's 8.60%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-91.95%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-81.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
233.46%
Positive 5Y CAGR while ACB.TO is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-47.78%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-1691.31%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-637.63%
Negative 5Y OCF/share CAGR while ACB.TO is at 91.47%. Joel Greenblatt would question the firm’s operational model or cost structure.
-556.05%
Negative 3Y OCF/share CAGR while ACB.TO stands at 91.11%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-5853.83%
Negative 10Y net income/share CAGR while ACB.TO is at 95.42%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-133.36%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
82.42%
3Y net income/share CAGR 75-90% of ACB.TO's 99.84%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
5683.87%
10Y equity/share CAGR above 1.5x ACB.TO's 167.97%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-29.32%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-23.00%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.38%
Our AR growth while ACB.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
8.89%
We show growth while ACB.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.63%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-5.64%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-5.92%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-29.11%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
7.54%
SG&A growth well above ACB.TO's 9.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.